相关实验视频
Updated: Sep 12, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
怀孕糖尿病的持续血糖监测系统:一个叙事审查
Melanie Rodacki1, Marcio Krakauer2, Denise Reis Franco3
1Internal Medicine Department, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. melanierodacki@gmail.com.
Diabetology & metabolic syndrome
|August 9, 2025
概括
持续血糖监测 (CGM) 为怀孕期间糖尿病管理提供了宝贵的见解. 它有助于改善血糖控制和检测葡萄糖波动,这对于所有类型糖尿病患者的更好的孕产妇和胎儿结果至关重要.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 怀孕期间的糖尿病对母亲和胎儿的健康构成重大风险,包括慢性并发症.
- 像HbA1c和血糖监测 (BGM) 这样的传统方法在提供全面的血糖数据方面存在局限性.
研究的目的:
- 审查持续血糖监测 (CGM) 在管理所有形式的妊娠糖尿病的临床效用.
- 强调CGM衍生指标在评估和改善血糖控制中的作用.
主要方法:
- 文献综述侧重于CGM在1型糖尿病,2型糖尿病和妊娠期糖尿病 (GDM) 怀孕中的应用和结果.
- 分析CGM衍生的指标,如时间范围 (TIR) 和平均葡萄糖水平.
主要成果:
- CGM提供了超越HbA1c和BGM的血糖控制的全面评估.
- 包括TIR在内的CGM衍生的指标与不良怀孕结果有关,突出了优化葡萄糖管理的必要性.
- 在因糖尿病而复杂的怀孕中,CGM有效检测葡萄糖的波动.
结论:
- 持续的葡萄糖监测是优化妊娠中血糖控制的重要工具,孕妇患有1型,2型和妊娠期糖尿病.
- 利用CGM指标可以通过及时干预来改善母亲和胎儿的结果.
- 常规基因组促进了对葡萄糖变化的更深入的理解,这对于在怀孕期间个性化糖尿病管理至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Hypoglycemia and Glucagon
335
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
335
Glucose Homeostasis: Regulation of Blood Glucose
2.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.5K
Diabetes: Management and Pharmacotherapy
374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374

